Emerging Strategies for Treating Brain Metastases from Breast Cancer

被引:121
|
作者
Kodack, David P. [1 ,2 ]
Askoxylakis, Vasileios [1 ,2 ]
Ferraro, Gino B. [1 ,2 ]
Fukumura, Dai [1 ,2 ]
Jain, Rakesh K. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Edwin L Steele Lab, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
关键词
NERVOUS-SYSTEM METASTASES; PROPHYLACTIC CRANIAL IRRADIATION; TUMOR-CELLS; TRASTUZUMAB EMTANSINE; KINASE INHIBITOR; OPEN-LABEL; PHASE-II; SURVIVAL; GROWTH; LAPATINIB;
D O I
10.1016/j.ccell.2015.01.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Brain metastasis is an end stage in breast cancer progression. Traditional treatment options have minimal efficacy, and overall survival is on the order of months. The incidence of brain metastatic disease is increasing with the improved management of systemic disease and prolongation of survival. Unfortunately, the targeted therapies that control systemic disease have diminished efficacy against brain lesions. There are reasons to be optimistic, however, as emerging therapies have shown promise in preclinical and early clinical settings. This review discusses recent advances in breast cancer brain metastasis therapy and potential approaches for successful treatment.
引用
收藏
页码:163 / 175
页数:13
相关论文
共 50 条
  • [41] Systemic treatment of brain metastases from breast cancer
    Taillibert, S.
    Conforti, R.
    Bonneterre, J.
    Bachelot, T.
    Le Rhun, E.
    Bernard-Marty, C.
    CANCER RADIOTHERAPIE, 2015, 19 (01): : 36 - 42
  • [42] Management of Brain and Leptomeningeal Metastases from Breast Cancer
    Pellerino, Alessia
    Interno, Valeria
    Mo, Francesca
    Franchino, Federica
    Soffietti, Riccardo
    Ruda, Roberta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 26
  • [43] Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis
    Xiong, Siyi
    Tan, Xuanni
    Wu, Xiujuan
    Wan, Andi
    Zhang, Guozhi
    Wang, Cheng
    Liang, Yan
    Zhang, Yi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [44] Immunohistochemical profiles of brain metastases from breast cancer
    Yonemori, Kan
    Tsuta, Koji
    Shimizu, Chikako
    Hatanaka, Yutaka
    Hashizume, Kaoru
    Ono, Makiko
    Nakanishi, Yukihiro
    Hasegawa, Tadashi
    Miyakita, Yasuji
    Narita, Yoshitaka
    Shibui, Soichiro
    Fujiwara, Yasuhiro
    JOURNAL OF NEURO-ONCOLOGY, 2008, 90 (02) : 223 - 228
  • [45] Radiotherapeutic management of brain metastases from breast cancer
    Hayakawa K.
    Yamakawa M.
    Mitsuhashi N.
    Hasegawa M.
    Kawashima M.
    Sakurai H.
    Murata O.
    Nasu S.
    Kurosaki H.
    Niibe H.
    Breast Cancer, 1998, 5 (2) : 149 - 154
  • [46] Strategies in treating male breast cancer
    Cutuli, Bruno
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 193 - 202
  • [47] Emerging PARP inhibitors for treating breast cancer
    Robert, Marie
    Patsouris, Anne
    Frenel, Jean-Sebastien
    Gourmelon, Carole
    Augereau, Paule
    Campone, Mario
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (03) : 211 - 221
  • [48] Navigating the Blood-Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
    Terceiro, Lucas E. L.
    Ikeogu, Nnamdi M.
    Lima, Matheus F.
    Edechi, Chidalu A.
    Nickel, Barbara E.
    Fischer, Gabor
    Leygue, Etienne
    McManus, Kirk J.
    Myal, Yvonne
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [49] Emerging Therapeutic Strategies in Breast Cancer
    Cox, Kayla
    Alford, Brandon
    Soliman, Hatem
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (10) : 632 - 637
  • [50] Emerging nanotherapeutic strategies in breast cancer
    Blanco, Elvin
    Ferrari, Mauro
    BREAST, 2014, 23 (01): : 10 - 18